Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDD Versus VDD in Newly Diagnosed Multiple Myeloma
NCT03908138Phase 4Unknown
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lenalidomide in multiple myeloma (MM), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03908138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908138.